So everything is pointing to the now officially announced Mobvoi...

So everything is pointing to the now officially announced Mobvoi launch next week being the much anticipated joint venture launch of the first smartwatch using ATCOR’s patented SphygmoCor® technology. It is worth revisiting releases from the last 20 months that directly relate to this activity to understand the enormity of this launch for CardieX. In the words of Big Kev, "I'm excited!" .

11 September 2019 - Joint Venture with Largest Google Wearable Platform in China

- we announced a JV agreement which provides for the co-development of consumer health applications and features forMobvoi’s line of smart wearable and watch solutions.

- the aim was to facilitate co-development activities that combine the algorithms and software of CardieX’s subsidiaryATCOR and Mobvoi’s sensor technology into a unique and market leading wearable consumerhealth platform on Google’s Wear OS platform.

29 January 2020 - CardieX Engages MEDL Mobile for App SaaS & Cloud Development

- CardieX engages leading mobile App, and software infrastructure developer MEDL Mobile toundertake the development and design of features and applications to be incorporated into the Mobvoismart-watch pursuant to the CardieX/Mobvoi Joint Development Agreement

24 April 2020 - Major Milestone Development of Wearable Sensor Technology

- ATCOR completeda significant milestone in its engineering & technology program and has derived a series of unique andheart and arterial health features from a PPG sensor based on the Company’s core SphygmoCor®technology.

- Results to be shortly presented to ATCOR wearables partner Mobvoi, Google’s official partnerin China for Google’s Wear OS platform.

- This involves a complex and significant technology and engineering effort in order to extract awaveform from a wearable (PPG or other) sensor that is equivalent to our current FDA cleared device –which is considered the “gold standard” for measuring an aortic arterial pressure waveform withcardiovascular related features.

PPG Sensor Development and Focus

We have determined that we can extract a waveform from a PPG sensor that is equivalent to ourSphygmoCor ® derived waveform and from that we open the path to the further measurement of anumber of other clinically relevant vital signs.PPG sensors are one of the most widely used optical sensor arrays on wearable devices consisting ofLEDs and photodetectors. Most PPG sensors are used to create consumer-grade capabilities, such asheart rate measurement and other general fitness features. They are usually represented by acombination of red, green, and infrared light diodes on wearables and smart watches.The key principle here is that we have determined that we can extract a substantially equivalentperformance to our FDA cleared technology central arterial waveform and cardiovascular relatedfeatures from a PPG sensor that we had previously.

24 September 2020 - Commercial Partnership with Mobvoi for New Health Smartwatch

- We announce a new commercial partnership agreement tolaunch a new line of smartwatch with heart and arterial health management features basedaround CardieX subsidiary ATCOR’s patented SphygmoCor® technology.. The new commercial partnership follows the Joint Development Agreement initiated betweenthe parties in 2019.

- CardieX and Mobvoi to jointly launch the world’s first smartwatch to feature ATCOR’s HeartStress™, Arterial Age™, Exercise Capacity™ (eCAP™) and Arty™ Score with active communityand AI-powered health coaching services.

- New Mobvoi smartwatch will be marketed with Health360™ premium subscription servicepowered by CardieX with a revenue-share split.

- Revenues to CardieX include subscription fees from CardieX-developed Health360™premium services and product sale revenues based on direct to consumer sales anddistribution rights. Mobvoi to also guarantee Minimum Order Quantities (MOQ’s) to CardieXfor a two (2) year period upon full market release.

- Profit from the generation of a sale will be solely for the party which has made the sale;
- Mobvoi will pay a revenue-share to CardieX for subscription fees received during both thelimited and full market release;
- Mobvoi will pay a royalty to CardieX on the sale of the products at a rate that will bedetermined between the parties prior to full market release; - CardieX has the option to be a worldwide (or other defined markets) distributor.


Let the fun commence !